Mai Capital Management Seelos Therapeutics, Inc. Transaction History

Mai Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.16 - $1.64 $133,553 - $1.37 Million	-834,707 Reduced 98.04%	16,695 $3,000
Q2 2023 Aug 02, 2023	SELL	$0.66 - $1.22 $50,173 - $92,744	-76,020 Reduced 8.2%	851,402 $1.02 Million
Q1 2023 May 10, 2023	SELL	$0.59 - $1.04 $55,805 - $98,369	-94,586 Reduced 9.25%	927,422 $639,000
Q4 2022 Feb 09, 2023	SELL	$0.66 - $259.46 $137,809 - $54.2 Million	-208,802 Reduced 16.96%	1,022,008 $694,000
Q3 2022 Nov 15, 2022	BUY	$0.65 - $278.68 $470,206 - $202 Million	723,394 Added 142.56%	1,230,810 $1.27 Million
Q2 2022 Jul 19, 2022	BUY	$0.51 - $0.93 $258,782 - $471,896	507,416 New	507,416 $345,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.